Progressive Corp <PGR.N>: Morgan Stanley raises to equal-weight from underweight; raises target price to $210 from $190
PGR•Related News
Cocrystal Pharma Q2 FY26 net loss widens to $3.16 million; R&D expense climbs to $2.14 million
COCP•
Pelthos Therapeutics posts investor deck outlining dermatology portfolio strategy centered on Zelsuvmi launch, Xepi and Xeglyze additions
PTHS•
Rocket Lab falls on $1.94 billion stock sale program
RKLB•
Cellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. Hogan
CLBT•
Vertical Aerospace Q2 FY26 net loss widens to GBP 42.13 million; operating loss rises to GBP 41.45 million
EVTL•